MATTEUCCI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 23.681
EU - Europa 2.309
AS - Asia 1.151
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 11
OC - Oceania 8
AF - Africa 1
Totale 27.176
Nazione #
US - Stati Uniti d'America 23.670
SG - Singapore 606
IT - Italia 525
CN - Cina 403
DE - Germania 349
UA - Ucraina 325
FR - Francia 242
IE - Irlanda 241
RU - Federazione Russa 152
PL - Polonia 131
GB - Regno Unito 97
SE - Svezia 95
FI - Finlandia 79
KR - Corea 76
IN - India 23
ES - Italia 15
EU - Europa 15
BE - Belgio 14
CZ - Repubblica Ceca 12
CA - Canada 9
JP - Giappone 9
NL - Olanda 9
UZ - Uzbekistan 9
PK - Pakistan 8
AU - Australia 7
HK - Hong Kong 7
AT - Austria 6
BR - Brasile 5
CL - Cile 5
CH - Svizzera 4
AL - Albania 2
EE - Estonia 2
MX - Messico 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
VN - Vietnam 2
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 27.176
Città #
Woodbridge 7.073
Wilmington 6.389
Houston 5.856
Fairfield 602
Ann Arbor 536
Singapore 508
Chandler 485
Jacksonville 291
Ashburn 289
Seattle 248
Dublin 236
Rome 222
Cambridge 221
Medford 172
Zhengzhou 139
Kraków 127
Santa Clara 124
Beijing 115
Dearborn 108
Lawrence 77
New York 61
Boardman 45
Menlo Park 42
Milan 40
Mülheim 37
San Diego 35
Moscow 32
Shanghai 28
Palo Alto 22
Munich 17
Mountain View 15
Nanjing 15
Brussels 14
Kunming 14
University Park 14
Verona 14
Falls Church 13
Portici 13
Brno 12
Helsinki 12
Norwalk 12
San Mateo 12
Redwood City 11
Guangzhou 10
London 10
Nürnberg 10
Jinan 8
Los Angeles 8
Madrid 8
Seoul 8
Toronto 8
Creede 7
Hefei 7
Bologna 6
Chengdu 6
Lahore 6
Nuremberg 6
Phoenix 6
Cagliari 5
Fuzhou 5
Genzano di Roma 5
La Veta 5
Paris 5
Ridgeland 5
Torino 5
Chongqing 4
Council Bluffs 4
Hangzhou 4
Kilburn 4
Naples 4
Redmond 4
Sassari 4
Vienna 4
Amsterdam 3
Catania 3
Detroit 3
Engelhard 3
Florence 3
Forlì 3
Frankfurt am Main 3
Genoa 3
Groningen 3
Hebei 3
Hounslow 3
Lappeenranta 3
Marano Di Napoli 3
Monterotondo 3
Nanchang 3
Pescara 3
Potenza 3
Pune 3
Saint Petersburg 3
San Francisco 3
St. George 3
São Paulo 3
Tai Po Kau 3
The Dalles 3
Washington 3
Xi'an 3
Anzio 2
Totale 24.609
Nome #
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 483
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression 468
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1. 461
Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells 457
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 449
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 445
Effect of phosphonated carbocyclic 2’-oxa-3’-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro 443
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis. 442
Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry 441
Modulation of apoptosis during HTLV-1-mediated immortalization process in vitro 436
Human endogenous retroviruses and ADHD 435
Thymosin alpha 1: from bench to bedside 433
Defective Fas ligand production in lymphocytes from MS patients 432
Analisi dell’espressione di retrovirus endogeni umani (HERV) in linfomonociti di soggetti sani di varie eta’: indicazioni per un possibile ruolo nello sviluppo 431
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 431
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 428
activation of human endogenous retrovirus k and cellular modifications in human melanoma cell line: gene expression analysis 426
Leucocyte rheological properties are altered in patients with diffuse atherosclerosis 424
Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis 418
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 417
Activation of human endogenous retrovirus k (herv-k) and cellular modifications in a human melanoma cell line: trascriptional profiling analysis 414
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 413
Ruolo eziopatogenetico dei retrovirus endogeni umani: il caso del melanoma 409
Adhd and human endogenous retroviruses 408
Thymosin α1 and cancer: action on immune effector and tumor target cells 407
Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis 406
Activation of human endogenous retrovirus K and cellular modifications in human melanoma cell line: gene expression analysis 406
Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry 405
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 403
Analisi filogenetica di un isolato di herv-k ottenuto da una lesione di melanoma metastatico umano. 403
Immunological and endocrinological disturbances in patients after prolonged coma following head injury 398
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS K AND CELLULAR MODIFICATIONS IN HUMAN MELANOMA CELL LINE: GENE EXPRESSION ANALYSIS. 393
Efficacy of 3 '-azido 3 ' deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells 392
Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis 392
INFLUENZA DEL MICROAMBIENTE SULLA PLASTICITA’ DI CELLULE DI MELANOMA ESPRIMENTI HERV-K. 388
Modificazione Fenotipica Ed Espressione Di Herv-K In Cellule Di Melanoma: Analisi Dell’espressione Genica Mediante Microarray. 387
Thymosin αlpha1 potentiatesthe release of antiviral factors by cd8+ cells: new tools for antiviral therapy 385
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 382
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 380
Inibitori Delle Istone Deacetilasi Riattivano Il Retrovirus Endogeno Umano-K In Cellule Di Melanoma Umano 380
High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma 377
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 377
ENDOGENOUS RETROVIRUS EXPRESSION IN TWO MOUSE MODELS OF AUTISM SPECTRUM DISORDERS. 373
Retrotransposon-Encoded Reverse Transcriptase in the Genesis, Progression and Cellular Plasticity of Human Cancer 365
HERVs expression in autism spectrum disorders 364
Immunological events during the early phase of infection with Schistosoma mansoni in mice 362
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS-K AND PRODUCTION OF INFECTIOUS VIRUS-LIKE PARTICLES IN HUMAN MELANOMA CELLS ABS -0153 358
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy 357
Human Endogenous Retroviruses-K (HERV-K) expression correlates with stemness features in melanoma cells. 357
Modulation of Apoptosis During HTLV-1-Mediated Immortalization Process In Vitro 356
HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features 356
Effector caspase activation, in the absence of a conspicuous apoptosis induction, in mononuclear cells treated with azidothymidine 351
null 342
Effetto di inibitori della trascrittasi inversa su cellule staminali tumorali di melanoma umano esprimenti HERV-K. 340
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB. 339
Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro 335
Human endogenous retrovirus in autism spectrum disorder 328
Survivin-Igm Immuno Complex: A Novel Candidate Biomarker Of Cirrhosis To Monitor Patients Progression Towards Hepatocellular Carcinoma 325
Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy 324
Carbon Nanotubes: Angels or Demon? Application in Biology and Medicine 318
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD 311
The human endogenous retrovirus K (HERV-K) has a role in melanoma cancer stem cells plasticity. 306
Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases 304
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders 300
Transcriptional activity of human endogenous retrovirus in Albanian children with autism spectrum disorders 269
I retrovirus endogeni nella sindrome da deficit di attenzione e iperattività (ADHD). 254
Children with autism spectrum disorder and their mothers share abnormal expression of selected endogenous retroviruses families and cytokines 190
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 160
The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs 149
High-throughput label-free characterization of viable, necrotic and apoptotic human lymphoma cells in a coplanar-electrode microfluidic impedance chip 133
Early Behavioral Alterations and Increased Expression of Endogenous Retroviruses Are Inherited Across Generations in Mice Prenatally Exposed to Valproic Acid 128
Endogenous retroviruses activity as a molecular signature of neurodevelopmental disorders 113
Antiretroviral therapy in HTLV-1 infection: an updated overview 107
Human endogenous retroviruses role in cancer cell stemness 106
MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia 68
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 57
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 52
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 50
Modulation of human endogenous retroviruses and cytokines expression in peripheral blood mononuclear cells from autistic children and their parents 42
Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents 41
Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity 41
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 40
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations 40
Differential Expression of Endogenous Retroviruses and Inflammatory Mediators in Female and Male Offspring in a Mouse Model of Maternal Immune Activation 39
Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children 36
Antioxidant phytocomplexes extracted from pomegranate (Punica granatum L.) using hydrodynamic cavitation show potential anticancer activity in vitro 31
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 31
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 30
Update of Respiratory Viruses Infection Rate in the Pandemic SARS-CoV-2 Period in Symptomatic Patients (December 2021-April 2023) 29
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 26
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 26
Multidistrict Host-Pathogen Interaction during COVID-19 and the Development Post-Infection Chronic Inflammation 25
First Evidence of Pathogenic HERV-W Envelope Expression in T Lymphocytes in Association with the Respiratory Outcome of COVID-19 Patients 25
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 24
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 23
The transactivation of endogenous retroviruses correlates with HIV reservoir, lymphocytes activation and low CD4 count in virologically suppressed patients 22
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors 22
Editorial: Unravelling the Role of HERVs in Cancer: Insights and New Targets for Therapy 22
IN VITRO ACTIVATION OF INFECTIOUS HERV-K: IMPLICATION IN MELANOMA PROGRESSION 20
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 17
Totale 27.464
Categoria #
all - tutte 55.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.579 0 0 0 0 518 717 602 606 553 611 470 502
2020/20214.422 539 526 504 614 423 454 540 435 104 88 160 35
2021/2022820 42 109 22 27 17 81 40 32 60 75 74 241
2022/20231.341 136 107 49 166 106 272 83 120 94 11 161 36
2023/2024533 77 22 35 13 46 95 30 38 12 36 21 108
2024/20251.216 86 594 311 170 55 0 0 0 0 0 0 0
Totale 27.523